The constant search for new pharmacologically active compounds, especially those that do
not exhibit toxic effects, intensifies the interest in plant-based ingredients and their potential …

Cannabis sativa L. turned out to be a valuable source of chemical compounds of various
structures, showing pharmacological activity. The most important groups of compounds …

Phytocannabinoids are naturally occurring compounds, the main source of which is
Cannabis sativa L. Through direct action or interaction with G protein-coupled receptors …

Central nervous system (CNS) disorders and diseases are expected to rise sharply in the
coming years, partly because of the world's aging population. Medicines for the treatment of …

Cannabis belongs to the family Cannabaceae, and phytocannabinoids are produced by the
Cannabis sativa L. plant. A long-standing debate regarding the plant is whether it contains …

Cannabinoid receptors type 1 (CB1) and 2 (CB2) are widely expressed in the human body,
and are attractive drug targets in the prevention and management of central nervous system …

Antimicrobial resistance has emerged as a global health crisis and, therefore, new drug
discovery is a paramount need. Cannabis sativa contains hundreds of chemical constituents …

Leading neurodegenerative diseases Alzheimer's disease (AD) and Parkinson's disease
(PD) are characterized by the impairment of memory and motor functions, respectively …

In this proof-of-concept study, the antioxidant activity of phytocannabinoids, namely
cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC), were investigated using an in vitro …

The medicinal properties of cannabis and the its legal status in several countries and
jurisdictions has spurred the massive growth of the cannabis economy around the globe …